Predicting prostate cancer many years before diagnosis: how and why?

Evidence of reduced prostate cancer mortality from randomized trials in Europe supports early detection of prostate cancer with prostate-specific antigen (PSA). Yet PSA screening has generated considerable controversy: it is far from clear that the benefits outweigh risks, in terms of overdiagnosis...

תיאור מלא

מידע ביבליוגרפי
Main Authors: Vickers, A, Lilja, H
פורמט: Journal article
שפה:English
יצא לאור: 2012

פריטים דומים